Zusammenfassung
Der Serumkalziumspiegel wird in engen Grenzen (2,2-2,6 mM) konstant gehalten. Die Konstanz der extrazellulären Kalziumkonzentration ist für eine Reihe von Stoffwechselvorgängen im Körper essenziell: die Modulation der Sekretion von Hormonen und anderen Substanzen, die Erregbarkeit von Nervenzellen und die Konstanz der Nervenleitfähigkeit, die Zellproliferation, die Blutgerinnung, bei der Kalzium ein Kofaktor ist, die Modulation von zahlreichen Enzymen z.B. der Glukoneogenese, der Glykogenolyse und der Mineralisierung von neu gebildeter Knochengrundsubstanz. Die Änderung der Serumkalziumkonzentration durch die Hormone der Kalziumhomöostase, Parathormon (PTH) und Vitamin-Ir-Hormon [1,25-Dihydroxycholecalciferol: 1,25(OH)2D3], innerhalb des Normbereichs dient zur Modulation dieser verschiedenen Stoffwechselfunktionen (Hurwitz 1996).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L (1994) An autosomal locus causing autoimmune disease, autoimmune polyglandular disease typ I assigned to chromosome 21. Nat Genet 8:83–87
Abdel AY, Auger LT, El-Gharbawy F (1989) Kenny-Caffey syndrome. Case report and literature review. Clin Pediatr (Phila) 28:175–179
Abramowicz MJ, Cochaux P, Cohen LH, Vamos E (1996) Pernicious anaemia and hypoparathyroidism in a patient with Kearns-Sayre syndrome with mitochondrial DNA duplication. J Inherit Metab Dis 19:109–111
Agarwal SK, Kester MB, Debelenko LV et al. (1997) Germline mutat ions of the MEN 1 gene in familial multiple endocrine neoplasia type land related states. Hum Mol Genet 6:1169–1175
Ahonen P (1985) Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 27:535–542
Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathycandidiasis-ectoderrnal dystrophy (APECED) in aseries of 68 patients. N Engl J Med 322:1829–1836
Arnold A, Kim HG (1989) Clonal loss of one chromosome 11 in a parathyroid adenom a. J Clin Endocrinol Metab 69:496–499
Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM (1988) Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658–662
Arnold A, Kim HG, Gaz RD et al. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with parathyroid hormone in a parathyroid adenoma. J Clin Invest 83:2034–2040
Arnold H, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86:1084–1087
Arnold A, Brown MF, Urena P, Gaz RD, Sarfali E, Drueke TB (1995) Monoclonality of parathyro id tumors in chronic renal failure and primary parathyroid hyperplasia. J Clin Invest 95:2047–2053
Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the RET proto-oncogene by multiple endocrine neoplasia 2A mutat ions. Mol Cell Biol 15:1613–1619
Bai M, Janicic N, Trivedi S et al. (1997a) Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 99:1917–1925
Bai M, Pearce SHS, Kifor O et al. (1997b) In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99:88–96
Berndt I, Reuter M, Salier B et al. (1998) A new hotspot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83:770–774
Blind E, Raue F, Götzmann J, Schmidt-Gayk H, Kohl B, Ziegler R (1992) Circulating levels of parathyroid hormonerelated protein in hypercalcemia of malignancy. Clin Endocrinol (Oxf) 37:290–297
Brown EM, Hebert SC (1997) Calcium-receptor-regulated parathyroid and renal function. Bone 20:303–309
Brown EM, Pollack M, Seidman JG, Chou Y-HW, Riccardi D, Hebert SC (1995a) Calcium-ion-sensing cell-surface receptors. N Engl J Med 333:234–240
Brown EM, Vassilev PM, Hebert SC (1995b) Calcium ions as extracellular messengers. Cell 83:679–682
Budarf ML, Collins J, Gong W et al. (1995) Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 10:269–278
Capes-Davis A, Robinson BG (1999) Return of the native: deducing the normal function of the RET proto-oncogene. Curr Opin Endocrinol Diabetes 6:61–69
Carling T, Ridefelt P, Hellman P, Rastad J, Ackerström G (1997) Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 82:1772–1775
Carling T, Correa P, Hessman O et al. (1998) Parathyroid MEN 1 gene mutat ions in relation to clinical characteristies of non familial primary hyperparathyroidism. J Clin Endocrinol Metab 83:2960–2963
Chandrasekharappa SC, Guru SC, Maniekam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407
Chattopadhyay N, Vassilev PM, Brown EM (1997) Calciumsensing receptor: roles in and beyond systemic calcium homeost asis. Biol Chem 378:759–768
Chelly J, Concordet JP, Kaplan JC, Kahn A (1989) Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA86:2617–2621
Cohen J, Gierlowsky TC, Schneider AB (1990) A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA 263:581–584
Cole DEC, Janicic N, Salisbury SR, Hendy GN (1997) Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciurie hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 71:202–210
Cryns VL, Rubio M-P, Thor AD, Louis DN, Arnold A (1994a) p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324
Cryns VL, Thor A, Xu H-J et al. (1994b) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761
Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A (1995) Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer 13:9–17
De-Luca F, Ray K, Mancilla EE et al. (1997) Sporadie hypoparathyroidism caused by de novo gain-of function mutations of the Ca(2+)-sensing receptor. J Clin Endocrinol Metab 82:2710–2715
Dionisi CV, Garavaglia B, Burlina AB et al. (1996) Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 129:159–162
Dotzenrath C, Teh BT, Farnebo F et al. (1996) Allelic loss of the retinobla stoma tumor suppressor gene: a marker for aggressive parathyro id tumors? J Clin Endocrinol Metab 81:3194–3196
Drenzer M, Neelon FA, Lebovitz HE (1973) Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclie AMPsignal. N Engl J Med 289:1056–1060
Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA 276:1575–1579
Falchetti A, Bale AE, Amorosi A et al. (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139–144
Falchetti A, Morelli A, Amorosi A et al. (1997) Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82:2278–2282
Farfel Z, Bourne HR, Iiri T (1999) The expanding spectrum of G protein diseases. N Engl J Med 340:1012–1020
Farnebo F, Enberg U, Grimelius L et al. (1997a) Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82:3481–3486
Farnebo F, Farnebo LO, Nordenström I, Larsson C (1997b) Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcemic secondary hyperparathyroidism. Eur J Surg 163:331–337
Franceschini P, Testa A, Bogetti G et al. (1992) Kenny-Caffey snydrome in two sibs born to consanguineous parents: evidence of an autosomal recessive variant. Am J Med Genet 42:112–116
Frank-Raue K, Höppner W, Frilling A et al. (1996) Mutations in the RET proto-oncogene in German MEN families: relation between genotype and phenotype. J Clin Endocrinol Metab 81:1780–1783
Frank-Raue K, Höppner W, Buhr H, Herfarth C, Raue F (1997) Results and follow-up in eleven MEN 2A gene carriers after prophylactie thyroidectomy. Exp Clin Endocrinol Diabetes [Suppl 4] 105:76–78
Friedman E, Bale AE, Marx SJ et al. (1990) Genetic abnormalities in sporadie parathyroid adenomas. J Clin Endocrinol Metab 71:293–297
Friedman E, Marco L de, Gejman PVet al. (1992) Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 52:6804–6809
Friedman E, Sakaguchi K, Bale AE et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213–218
Fugazzola L, Pilotti S, Pinchera A et al. (1995) Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55:5617–5620
Fujiwara S, Sposto R, Ezaki H et al. (1992) Hyperparathyroidism among atomic bomb survivors in Hiroshima. Radiat Res 130:362–378
Fukomoto S, Suzawa M, Takeuchi Y et al. (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism typ Ib. J Clin Endocrinol Metab 81:2554–2558
Fukuda N, Tanaka H, Tominaga Y, Fukagaw M, Kurokawa K, Seino Y (1993) Decreased 1,25-dihydroxy vitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443
Fuleihan GE-H, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA (1997) The parathyroid hormone circadian rhythm is truly endogenous — a general clinical research center study. J Clin Endocrinol Metab 82:281–286
Fuleihan GE, Seifter J, Scott J, Brown EM (1998) Calciumregulated renal calcium handling in healthy men: relationsh ip to sodium handling. J Clin Endocrinol Metab 83:2366–2372
Fusco A, Grieco M, Santoro M et al. (1987) A new oncogene in human-thyroid papillary carcinoma and their lymph nodal metastases. Nature 328:170–172
Gama L, Baxendale-Cox LM, Breitwieser GE (1997) Ca2+-sensing receptors in intestinal epithelium. Am J Physiol 273:C1168–C1175
Glover D, Riley L, Carmichael K et al. (1983) Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioactive and chemoprotective agent). N Engl J Med 309:1137–1147
Gogusey J, Duchambon P, Hory B et al. (1997) Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328–326
Goodmann WG, Veldhuis JD, Belin TR, Herle AJ van, Juppner H, Salusky IB (1998) Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. J Clin Endocrinol Metab 83:2765–2772
Grieco M, Santoro M, Berlingieri MT et al. (1990) PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563
Guise TA (1997) Parathyroid hormone-related protein and bone metastases. Cancer 80:1572–1580
Guise TA, Yin JJ, Taylor SD et al. (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544–1549
Hakim JP, Levine MA (1994) Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103–106
Hall JG (1997) Genomic imprinting: nature and clinical relevance. Annu Rev Med 48:35–44
Heath H (1989) Familial benign (hypocalciuric) hypercalcemia. A trouble-some mimic of mild primary hyperparathyroidism. Med Clin North Am 18:723–740
Heath DA (1994) Familial hypocalciuric hypercalcemia. In: Bilezikan JP (ed) The parathyroids. Raven Press, New York, pp 699–710
Heath III H, Odelberg S, Jackson CE et al. (1996) Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81:1312–1317
Heppner C, Kester MB, Agarwal SK et al. (1997) Somatic mutation of the MEN 1 gene in parathyroid tumours. Nat Genet 16:375–378
Hosokawa Y, Pollak MR, Brown EM, Arnold A (1995) Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107–3110
Hsi ED, Zukerberg LR, Yang W-I, Arnold A (1996) Cyclin DI/PRADI expression in parathyroid adenomas: an immunohistological study. J Clin Endocrinol Metab 81:1736–1739
Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH (1997) Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 21:22–28
Hurwitz S (1996) Homeostatic control of plasma calcium concentration. Crit Rev Biochem Mol Biol 31:41–100
Isotani H, Fukumoto Y, Kawamura H et al. (1996) Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNAdeletion. Clin Endocrinol (Oxf) 45:637641
Jackson CE, Norum RA, Boyd SB et al. (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006–1013
Jenkins PJ, Satta MA, Simmgen M et al. (1997) Metastatic parathyroid carcinoma in the MEN 2A syndrome. Clin Endocrinol 47:747–751
Jobert AS, Zhang P, Couvineau A et al. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34–40
Juppner H, Schipani E, Basteppe M et al. (1998) The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds the chromosome 20q13.3. Proc Natl Acad Sci USA 95:11798–11803
Karaplis AC, SKL, Baba H, Arnold A, Kronenberg HM (1995) Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant prepropa rathyro id hormone protein. J Biol Chem 270:1629–1635
Kassem M, Zhang X, Brask S, Eriksen E, Mosekilde L, Kruse T (1994) Familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 41:415–420
Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath III H (1993) Calcium infusion suggests a “set-point” abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperp arathyroidism. J Clin Endocrinol Metab 76:715–720
Kifor O, Moore FD, Wang P et al. (1996) Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598–1606
Kimura T, Yoshimoto K, Tanaka C et al. (1996) Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol 134:314–319
Kobayashi M, Tanaka H, Tsuzuki K et al. (1997) Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 82:2716–2719
Kraimps J-L, Denizot A, Carnaille B et al. (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. World J Surg 20:808–813
Laitinen K, Lamberg AC, Tunninen R, Karonen SL, Tahtela R, Ylikahri R, Valimaki M (1991) Transient hypoparathyroidism during acute alcohol intoxication. N Engl J Med 324:721–727
Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome II and is lost in insuloma. Nature 332:85–87
Law WM, Hodgson SF, Heath H (1983) Autosomal recessive inheritance of familial hyperparathyroidism. N Engl J Med 306:650–653
Levine MA, Spiegel AM (1995) Pseudohypoparathyroidism. In: DeGroot LJ, Besser M, Burger HG (eds) Endocrinology. Saunders, Philadelphia, pp 1136–1150
Levine MA, Downs RW, Moses AM et al. (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Associated with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556
Levine MA, Ahn TG, Klupt SF et al. (1988) Genetic deficiency of the alpha subunit of the guanine nucleotidebinding Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 85:617–621
Lippuner K, Zehnder H-J, Casez J-P, Takkinen R, Jaeger P (1996) PTH-related protein is released into the mother’s bloodstream during lactation: evidence for beneficial effects on maternal calcium-phosphate metabolism. J Bone Miner Res 11:1394–1399
LiVolsi VA (1994) Embryology, anatomy, and pathology of the parathyroids. In: Bilezikian JP (ed) The parathyroids, basic and clinical concepts. Raven Press, New York, pp 1–14
Lubensky IA, Debelenko LV, Zhuang Z et al. (1996) Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN 1 patients. Cancer Res 56:5272–5278
Moraes CT, DiMauro S, Zeviani M et al. (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome (see comments). N Engl J Med 320:1293–1299
Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton I (1993) A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 2:2081–2087
Motokura T, Arnold A (1993) PRADI/cyclin D I proto-oncogene: genomic organization, 5’ DNA sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 7:89–95
Muller W, Peter HH, Wilken M et al. (1988) The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur I Pediatr 147:496–502
Mumm S, Whyte MP, Thakker RV, Buetow KH, Schlessinger D (1997) mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation. Am J Hum Genet 60:153–159
Nagant de Deuxchaisnes C, Krane SM (1978) Hypoparathyroidism. In: Avioli CV, Krane SM (eds) Metabolie bone disease. Academic Press, New York, pp 218–245
Padberg B-C, Sehröder S, Jochum W et al. (1995) Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am I Pathol 147:1600–1607
Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RSK, Arnold A (1998) Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenoma. J Clin Endocrinol Metab 83:1766–1770
Parfitt AM (1994) Parathyroid growth, normal and abnormal. In: Bilezikian JP (ed) The parathyroids. Raven Press, New York, pp 373–405
Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149–152
Pearce SHS, Brown EM (1996) The genetic basis of endocrine disease. Disorders of calcium ion sensing. J Clin Endocrinol Metab 81:2030–2035
Pearce SH, Williamson C, Kifor O et al. (1996) A familial syndrome of hypocalcemia with hypercaleiuria due to mutations in the calcium-sensing receptor (see comments). N Engl J Med 335:1115–1122
Pellock JM, Behrens M, Lewis L, Holub D, Carter S, Rowland LP (1978) Kearns-Sayre syndrome and hypoparathyroidism. Ann Neurol 3:455–458
Pollack MR, Brown EM, Chou Y-HW et al. (1993) Mutations in the human Ca2+-sensing receptor gene cause familial hypocaleiuric hyper calcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303
Pollak MR, Brown EM, Estepp HL et al. (1994) Autosomaldominant hypocalcemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8:303–307
Pott JT (1996) Hyperparathyroidism and other hypercalcemic disorders. Adv Intern Med 41:165–212
Raue F, Frank-Raue K, Grauer A (1994) Multiple endocrine neoplasia type 2, clinical features and screening. Endocrinol Metab Clin North Am 23:137–156
Raue F, Kraimps JL, Dralle H et al. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238:369–373
Rizzoli R, Pache J-C, Didierjean L, Bürger A, Bonjour l-P (1994) A thymoma as a cause of true ectopic hyperparathyro idism. J Clin Endocrinol Metab 79:912–915
Roskams T, Desmet V (1997) Parathyroid hormone-related peptides. A new class of multifunctional proteins. Am J Pathol 150:779–785
Sabry MA, Zaki M, Abul HS et al. (1998) Kenny-Caffey syndrome is part of the CATCH 22 haploinsuffieiency cluster. J Med Genet 35:31–36
Santoro M, Carlomagno F, Romano A et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267:381–383
Sarkar G, Sommer SS (1989) Access to a messenger RNA sequence or its protein products is not limited by tissue or species specificity (see comment s). Science 244:331–334
Scambler PI, Carey AH, Wyse RK et al. (1991) Microdeletion within 22q11 associated with sporadic anf familial DiGeorge syndrome. Genomics 10:201–206
Schilling T, Ziegler R (1996) The diagnosis and therapy of hypoparathyroidism. Dtsch Med Wochenschr 121:841–844
Schilling T, Ziegler R (1997) Current therapy of hypoparathyroidism — a survey of German endocrinology centers. Exp Clin Endocrinol Diabetes 105:237–241
Schipani E, Weinstein LS, Bergwitz C et al. (1995) Pseudohypoparathyroidism type Ib ist not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611–1621
Schipani E, Langman CB, Parfitt AM et al. (1996) Constitutively act ivated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal condrodysplasia. N Engl J Med 335:708–714
Schmitt CP, Schaefer F, Bruch A et al. (1996) Control of pulsatile and tonie parathyroid hormone secretion by ionized calcium. J C!in Endocrinol Metab 81:4236–4243
Schuffenecker I, Virally-Monod M, Brohet R et al. (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2 A families with mutations at codon 634 of the RET proto-oncogene. Groupe d’etude des tumeurs a caleitonine. J Clin Endocrinol Metab 83:487–491
Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677
Szabo J, Heath B, Hill VM et al. (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome lq21-q31. Am J Hum Genet 56:944–950
Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663–3667
Tahseen K, Khan S, Uma R et al. (1997) Kenny-Caffey syndrome in sex Bedouin sibships: autosomal recessive inheritance is confirmed. Am J Med Genet 69:126–132
Teh B, Farnebo F, Kristoffersson U et al. (1996) Autosomaldominant primary hyperparathyroidism and jaw tumour syndrome associated with renal hamartomas and cystic kidney disease: linkage to lq21-q32 and loss of heterozygosity of the wold type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204–4211
Thakker RV, Davies KE, Whyte MP, Wooding G, O’Riordan JL (1990) Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest 86:40–45
Thompson DB, Samowitz WS, Odelberg S, Davis RK, Szabo J, Heath III H (1995) Genetic abnormalities in sporadie parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J C!in Endocrinol Metab 80:3377–3380
Trump D, Farren B, Wooding C et al. (1996) Clinieal study of multiple endocrine neoplasia type 1 (MEN 1). Q J Med 89:653–669
Wilichowski E, Gruters A, Kruse K et al. (1997) Hypoparathyroidism and deafness associated with pleioplasmic large scale rearrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Pediatr Res 41:193–200
Williamson C, Cavaco BM, Jausch A et al. (1999) Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome lq22-q31. J Bone Miner Res 14:230–239
Wortsman J, Kumar V (1994) Case report: idiopathic hypoparathyroidism co-existing with celiac disease: immunologic studies. Am J Med Sci 307:420–427
Wynne AG, Heerden J van, Carney JA, Fitzpatriek LA (1992) Parathyroid carcinoma: clinical and pathological features in 43 patients. Medicine (Baltimore) 71:197–205
Yu S, Yu D, Hainline BE et al. (1995) A deletion hot-spot in exon 7 of the Gs alpha gene (GNAS1) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 4:2001–2002
Zahrani AA, Levine MA (1996) Primary hyperparathyroidism. Lancet 349:1233–1266
Zlotogora J, Shapiro MS (1992) Polyglandular auto immune syndrome type I among Iranian Jews, J Med Genet 29:824–826
Zucchi I, Mumm S, Pila G et al. (1996) YAC/STS map across 12 Mb of Xq27 at 25-kb resolution, merging Xq26-qter. Genomies 34:42–54
Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S (1991) Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29:680–683
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Raue, F., Schilling, T. (2001). Hyper- und Hypoparathyreoidismus. In: Ganten, D., Ruckpaul, K., Janssen, O.E., Heufelder, A.E. (eds) Molekularmedizinische Grundlagen von Endokrinopathien. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56858-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-56858-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63216-7
Online ISBN: 978-3-642-56858-9
eBook Packages: Springer Book Archive